Literature DB >> 33356832

Kv1.3 inhibition attenuates neuroinflammation through disruption of microglial calcium signaling.

Alla F Fomina1, Hai M Nguyen2, Heike Wulff2.   

Abstract

In the last 5 years inhibitors of the potassium channel KV1.3 have been shown to reduce neuroinflammation in rodent models of ischemic stroke, Alzheimer's disease, Parkinson's disease and traumatic brain injury. At the systemic level these beneficial actions are mediated by a reduction in microglia activation and a suppression of pro-inflammatory cytokine and nitric oxide production. However, the molecular mechanisms for the suppressive action of KV1.3 blockers on pro-inflammatory microglia functions was not known until our group recently demonstrated that KV1.3 channels not only regulate membrane potential, as would be expected of a voltage-gated potassium channel, but also play a crucial role in enabling microglia to resist depolarizations produced by the danger signal ATP thus regulating calcium influx through P2X4 receptors. We here review the role of KV1.3 in microglial signaling and show that, similarly to their role in T cells, KV1.3 channels also regulated store-operated calcium influx in microglia.

Entities:  

Keywords:  Kv1.3; Microglia activation; depolarization; neuroinflammation; store-operated calcium influx; voltage-gated potassium channel

Mesh:

Substances:

Year:  2021        PMID: 33356832      PMCID: PMC7781540          DOI: 10.1080/19336950.2020.1853943

Source DB:  PubMed          Journal:  Channels (Austin)        ISSN: 1933-6950            Impact factor:   2.581


  61 in total

1.  Elevation of basal intracellular calcium as a central element in the activation of brain macrophages (microglia): suppression of receptor-evoked calcium signaling and control of release function.

Authors:  Anja Hoffmann; Oliver Kann; Carsten Ohlemeyer; Uwe-Karsten Hanisch; Helmut Kettenmann
Journal:  J Neurosci       Date:  2003-06-01       Impact factor: 6.167

Review 2.  International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels.

Authors:  George A Gutman; K George Chandy; Stephan Grissmer; Michel Lazdunski; David McKinnon; Luis A Pardo; Gail A Robertson; Bernardo Rudy; Michael C Sanguinetti; Walter Stühmer; Xiaoliang Wang
Journal:  Pharmacol Rev       Date:  2005-12       Impact factor: 25.468

3.  Two different ionotropic receptors are activated by ATP in rat microglia.

Authors:  S Visentin; M Renzi; C Frank; A Greco; G Levi
Journal:  J Physiol       Date:  1999-09-15       Impact factor: 5.182

4.  Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.

Authors:  Christine Beeton; Heike Wulff; Nathan E Standifer; Philippe Azam; Katherine M Mullen; Michael W Pennington; Aaron Kolski-Andreaco; Eric Wei; Alexandra Grino; Debra R Counts; Ping H Wang; Christine J LeeHealey; Brian S Andrews; Ananthakrishnan Sankaranarayanan; Daniel Homerick; Werner W Roeck; Jamshid Tehranzadeh; Kimber L Stanhope; Pavel Zimin; Peter J Havel; Stephen Griffey; Hans-Guenther Knaus; Gerald T Nepom; George A Gutman; Peter A Calabresi; K George Chandy
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-06       Impact factor: 11.205

5.  Up-regulation of P2X2, P2X4 receptor and ischemic cell death: prevention by P2 antagonists.

Authors:  F Cavaliere; F Florenzano; S Amadio; F R Fusco; M T Viscomi; N D'Ambrosi; F Vacca; G Sancesario; G Bernardi; M Molinari; C Volontè
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

6.  The voltage-gated potassium channel Kv1.3 is required for microglial pro-inflammatory activation in vivo.

Authors:  Jacopo Di Lucente; Hai M Nguyen; Heike Wulff; Lee-Way Jin; Izumi Maezawa
Journal:  Glia       Date:  2018-07-25       Impact factor: 7.452

7.  The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke.

Authors:  Yi-Je Chen; Hai M Nguyen; Izumi Maezawa; Eva M Grössinger; April L Garing; Ralf Köhler; Lee-Way Jin; Heike Wulff
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-02       Impact factor: 6.200

8.  Involvement of Kv1.3 and p38 MAPK signaling in HIV-1 glycoprotein 120-induced microglia neurotoxicity.

Authors:  J Liu; C Xu; L Chen; P Xu; H Xiong
Journal:  Cell Death Dis       Date:  2012-01-19       Impact factor: 8.469

9.  Microglial Ramification, Surveillance, and Interleukin-1β Release Are Regulated by the Two-Pore Domain K+ Channel THIK-1.

Authors:  Christian Madry; Vasiliki Kyrargyri; I Lorena Arancibia-Cárcamo; Renaud Jolivet; Shinichi Kohsaka; Robert M Bryan; David Attwell
Journal:  Neuron       Date:  2017-12-28       Impact factor: 17.173

10.  Temporal profiling of Kv1.3 channel expression in brain mononuclear phagocytes following ischemic stroke.

Authors:  Tianwen Gao; Syed Ali Raza; Supriya Ramesha; Ngozi V Nwabueze; Amelia J Tomkins; Lihong Cheng; Hailian Xiao; Manuel Yepes; Srikant Rangaraju
Journal:  J Neuroinflammation       Date:  2019-06-01       Impact factor: 8.322

View more
  7 in total

Review 1.  Pathophysiological Responses to Conotoxin Modulation of Voltage-Gated Ion Currents.

Authors:  Elisabetta Tosti; Raffaele Boni; Alessandra Gallo
Journal:  Mar Drugs       Date:  2022-04-23       Impact factor: 6.085

2.  Conditional knockout of Tsc1 in RORγt-expressing cells induces brain damage and early death in mice.

Authors:  Yafei Deng; Qinglan Yang; Yao Yang; Yana Li; Hongyan Peng; Shuting Wu; Shuju Zhang; Baige Yao; Shuhui Li; Yuan Gao; Xiaohui Li; Liping Li; Youcai Deng
Journal:  J Neuroinflammation       Date:  2021-05-06       Impact factor: 8.322

3.  Potassium Channels Kv1.3 and Kir2.1 But Not Kv1.5 Contribute to BV2 Cell Line and Primary Microglial Migration.

Authors:  Ruxandra Anton; Mihail Ghenghea; Violeta Ristoiu; Christophe Gattlen; Marc-Rene Suter; Petre Alexandru Cojocaru; Aurel Popa-Wagner; Bogdan Catalin; Alexandru-Florian Deftu
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

4.  The potassium channel Kv1.3 as a therapeutic target for immunocytoprotection after reperfusion.

Authors:  Yi-Je Chen; Yanjun Cui; Latika Singh; Heike Wulff
Journal:  Ann Clin Transl Neurol       Date:  2021-10-07       Impact factor: 4.511

5.  GFP-Margatoxin, a Genetically Encoded Fluorescent Ligand to Probe Affinity of Kv1.3 Channel Blockers.

Authors:  Kristina R Denisova; Nikita A Orlov; Sergey A Yakimov; Elena A Kryukova; Dmitry A Dolgikh; Mikhail P Kirpichnikov; Alexey V Feofanov; Oksana V Nekrasova
Journal:  Int J Mol Sci       Date:  2022-02-02       Impact factor: 5.923

Review 6.  Microglia as Therapeutic Target for Radiation-Induced Brain Injury.

Authors:  Qun Liu; Yan Huang; Mengyun Duan; Qun Yang; Boxu Ren; Fengru Tang
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

Review 7.  The potential convergence of NLRP3 inflammasome, potassium, and dopamine mechanisms in Parkinson's disease.

Authors:  Adrianne F Pike; Ildikò Szabò; Robert Veerhuis; Luigi Bubacco
Journal:  NPJ Parkinsons Dis       Date:  2022-03-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.